Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lilly's new 5-ht1f agonists especially useful for migraine

June 8, 1999

NeoTherapeutics' lead compound ameliorates AD

June 8, 1999

Effects of T-588 on cerebral function studied in rats

June 7, 1999

SBIR award to CoCensys to discover caspase inhibitors for stroke

June 7, 1999

Ligands of brain nACh receptors designed at NeuroSearch

June 7, 1999

GDNF gene therapy approach to cerebrovascular disorders proven effective

June 4, 1999

Kinase inhibitor provides neuroprotection in focal cerebral ischemia

June 4, 1999

BASF discloses serotonergic agents for depression

June 4, 1999

New treatment for ALS available for licensing from Cornell Research Foundation

June 4, 1999

Repligen acquires additional capital for secretin trials in autism

June 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...